HOME >> BIOLOGY >> NEWS
APS President-Elect Carey urges 6.7 percent increase for biomedical research

WASHINGTON -- (March 27, 2007) Hannah V. Carey, Ph.D., president-elect of The American Physiological Society (APS; www.the-aps.org) and a professor at the University of Wisconsin School of Veterinary Medicine, today urged Congress to increase funding for the National Institutes of Health (NIH), the nations largest funding source for biomedical research. A 6.7 percent increase in funding for the next fiscal year will help solve pressing health problems such as obesity, heart disease, diabetes and cancer, Carey told the U.S. House Appropriations Subcommittee on Labor, Health and Human Services, and Education.

Carey expressed appreciation on behalf of the scientific community for doubling the NIH budget between 1998 and 2003. Since then, however, funding for the agency has not kept up with inflation. In fact, the NIH funds fewer than one out of five biomedical research grant applications, meaning that top-tier research is not being funded, Carey said. As a result, some of the best medical and scientific ideas are being left unexplored, and our most talented and creative scientists and our scientific leaders of the future are receiving a message of indifference.

Carey urged Congress to support a 6.7 percent increase for the NIH in each of the next three fiscal years. These increases would get the NIH back on track by restoring losses due to inflation in recent years. She also stressed the importance of NIH-funded training programs for the next generation of scientists and said NIH funds are essential to improving science education at all levels. The NIH also funds programs that provide important opportunities for minority students to become more deeply involved in scientific research.


'"/>

Contact: Christine Guilfoy
cguilfoy@the-aps.org
301-634-7253
American Physiological Society
27-Mar-2007


Page: 1

Related biology news :

1. Contributing membership in the biomarkers consortium surges to 30 companies and nonprofits
2. AAAS urges US President to sign Embryonic Stem Cell Act
3. Virginia study urges early emphasis on science
4. NIH panel urges more informed approach to multivitamin/mineral use for chronic disease prevention
5. New journal article urges use of animal serum-free media for growing live cells
6. US Surgeon General urges Americans to know their family health history
7. To stem disease, keep cats indoors, stop feeding strays, scientist urges
8. AAAS CEO Alan I. Leshner urges US to continue collecting job data on women workers
9. Study urges caution in contaminant source tracking
10. The CF Foundation urges all states to include newborn screening for cystic fibrosis in test panels
11. New study warns limited carbon market puts 20 percent of tropical forest at risk

Post Your Comments:
(Date:8/21/2014)... Conn. , Aug. 21, 2014 Nxt-ID, ... the growing mobile commerce market, announced today that its ... common stock to be issued in its proposed underwritten ... approved for listing on The Nasdaq Capital Market, subject ... the common stock and warrants, and will trade under ...
(Date:8/21/2014)... study aimed at improving the food intake, health and ... homes is among three projects at the University of ... the Canadian Institutes of Health Research (CIHR). , ... Sciences at Waterloo, and a Schlegel research chair in ... to investigate why many Canadians living in long-term care ...
(Date:8/21/2014)... , Saturday to Wednesday, Oct. 18-22, 2014 , ... W. Harbor Drive, San Diego, CA 92101 , ... and other presentations of the latest research in ... plenary session featuring high-scoring abstracts on rare genetic ... various cancers, and treatment for sun sensitivity (Saturday, ...
Breaking Biology News(10 mins):Nxt-ID Approved for NASDAQ Capital Market Listing 2Nxt-ID Approved for NASDAQ Capital Market Listing 3Grants will fund landmark aging research at Waterloo 2American Society of Human Genetics 2014 Annual Meeting 2
(Date:8/22/2014)... New York (PRWEB) August 22, 2014 ... one of the interesting and challenging endeavors as ... renders highly impervious properties to the foreign substances. ... as possibility of self medication and minimal use ... low molecular weight drugs and provides specific targeting ...
(Date:8/22/2014)... Aug. 22, 2014 Research and Markets ... Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, ... report to their offering. The global ... in 2013, and is expected to grow at a ... Molecular biology enzymes, kits, & reagents find applications in ...
(Date:8/22/2014)... Canada (PRWEB) August 22, 2014 ... in model organisms can be accelerated by exome ... and manufacturing technologies, the custom SeqCap EZ Developer ... research. , Mr. Watson will additionally present how ... with commercially available human and mouse exome kits. ...
(Date:8/21/2014)... MD (PRWEB) August 21, 2014 DNA ... making progress in its development of JRC-LAMP-vax, an innovative ... cedar pollen. Phase IC studies began this month in ... to hay fever. , The Japanese red cedar releases ... people in Japan. Mountain Cedar pollen wreaks similar havoc ...
Breaking Biology Technology:Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 4Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018 2Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018 3Efficient Identification of Protein-Coding Variants in a Model Organism Through Exome Sequencing, New Webinar Hosted by Xtalks 2Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 2Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 3Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 4
Cached News: